Clinical Trial

Proteomics in Small Cell Lung Cancer

Study acronym: SCLC-OMICS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 31, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to gather insight into tumor-derived circulating extracellular vesicles-proteins in patients with newly diagnosed small cell lung cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-11-14.
Status change: Not Yet Recruiting → Recruiting 2025-01-28
Trial Details
NCT Number NCT05623956
Lead Sponsor Aalborg University Hospital
Conditions Small Cell Lung Cancer
Enrollment 50 participants
Start Date 2023-03-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-31